Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: A population based study

Current Medical Research and Opinion

Volumn 25, Issue 8, 2009, Pages 1879-1888

  Iskedjian, Michael ^a   Walker, J H ^a,b   Desjardins, O ^a   Robin, A L ^c   Covert, D W ^d   Bergamini, M V W ^d   Einarson, T R ^a  

^a PharmIdeas Research and Consulting Inc   (Canada)

^b BROCK UNIVERSITY   (Canada)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d ALCON RESEARCH LTD   (United States)

Author keywords

Adjunctive therapy; Drug utilization; Glaucoma; Persistence; Population based study

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIMATOPROST; CALCIUM CHANNEL BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DORZOLAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LATANOPROST; LOOP DIURETIC AGENT; MIOTIC AGENT; MYDRIATIC AGENT; POTASSIUM SPARING DIURETIC AGENT; SULFONYLUREA; TIMOLOL; TRAVOPROST;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DATABASES AS TOPIC; DIURETICS; FEMALE; GLAUCOMA; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PROSTAGLANDINS, SYNTHETIC; QUEBEC; YOUNG ADULT;

EID: 67650799133     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903035083     Document Type: Article

References (38)

1. Varma R, Ying-Lai M, Francis B, et al. Prevalence of open-angle glaucoma and ocular hypertension in Latinos. The Los Angeles Latino Eye Study. Ophthalmology 2004;111:1439-48
2. The Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol 2004;122:532-8
3. Collaborative normal-tension glaucoma study group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998;126:498-505
4. The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:429-40
5. Gordon M, Beiser J, Brandt J, et al. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714-20
6. Leske M, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment. The early manifest glaucoma trial. Arch Ophthalmol 2003;121:48-56
7. Lichter P, Musch D, Gillespie B, et al. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Am J Ophthalmol 2001;108:1943-53
8. Schwartz K, Budenz D. Current management of glaucoma. Curr Opin Ophthalmol 2004;15:119-26
9. Alward W. Medical management of glaucoma. N Engl J Med 1998;339:1298-307
10. Soltau J, Zimmerman T. Changing paradigms in the medical treatment of glaucoma. Surv Ophthalmol 2002;47:S2-5
11. Semes L. Advances in glaucoma therapy. Optom Manage, 2006;41:94-8
12. Balkrishnan R, Bond J, Byerly W, et al. Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a Medicare health maintenance organization. Am J Geriatr Pharmacother 2003;1:75-81
13. Kass M, Heuer D, Higginbotham E, et al. A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13
14. Covert D, Robin A, Novack G. Systemic medications and glaucoma patients. Ophthalmology 2005;112:1849.e1-1849.e2
15. Cellini M, Possati G, Caramazza N, et al. The use of flunarizine in the management of low-tension glaucoma: a color Doppler study. Acta Ophthalmol Scand Supplement 1997;224:57-8
16. EGPS Group. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 2007;114:3-9
17. Hirooka K, Baba T, Fujimura T, et al. Prevention of visual field defect progression with angiotensin-converting enzyme inhibitor in eyes with normal-tension glaucoma. Am J Ophthalmol 2006;142:523-5
18. Klein R, Knudtson M, Klein B. Statin use and the five-year incidence and progression of age-related macular degeneration. Am J Ophthalmol 2007;144:1-6
19. Langman M, Lancashire R, Cheng K, et al. Systemic hypertension and glaucoma: mechanisms in common and co-occurrence. Br J Ophthalmol 2005;89:960-3
20. McGwin Jr G, McNeal S, Owsley C, et al. Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol 2004;122:822-6
21. Miglior S, Torri V, Zeyen T, et al. Intercurrent factors associated with the development of open-angle glaucoma in the European Glaucoma Prevention Study. Am J Ophthalmol 2007;144:266-75
22. Punjabi O, Stamper R, Bostrom A, et al. Does treated systemic hypertension affect progression of optic nerve damage in glaucoma suspects? Curr Eye Res 2007;32:153-60
23. Santafé J, Martinéz de Ibarreta M, Segarra J, et al. A long-lasting hypotensive effect of topical diltiazem on the intraocular pressure in conscious rabbits. Arch Pharmacol 1997;355:645-50
24. Shah G, Sharma S, Mehta A, et al. Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma. J Cardiovasc Pharmacol 2000;36:169-75
25. Shibuya T, Kashiwagi K, Tsukahara S. Comparison of efficacy and tolerability between two gel-forming timolol maleate ophthalmic solutions in patients with glaucoma or ocular hypertension. Ophthalmologica 2003;217:31-8
26. Song J, Deng P-F, Stinnett S, et al. Effects of cholesterol-lowering statins on the aqueous humor outflow pathway. Invest Ophthalmol Vis Sci 2005;46:2424-32.
27. Topouzis F, Coleman A, Harris A, et al. Association of blood pressure status with the optic disk structure in non-glaucoma subjects: The Thessaloniki Eye Study. Am J Ophthalmol 2006;142:60-7
28. van der Valk R, Webers C, Schouten J, et al. Intraocular pressure-lowering effects of all commonly used glaucoma drugs. A meta-analysis of randomized clinical trials. Ophthalmology 2005;112:1177-85
29. Yamamoto T, Niwa Y, Kawakami H, et al. The effect of nilvadipine, a calcium-channel blocker, on the hemodynamics of retrobulbar vessels in normal-tension glaucoma. J Glaucoma 1998;7:301-5
30. RAMQ. Databank of official statistics on Quebec. Number of subscribers at age over 65 and under 65 [database]. Québec, Canada: Régie de l'assurance maladie Québec. Updated 24 May 2007
31. Tamblyn R, Lavoie G, Petrella L, et al. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995;48:999-1009
32. CPA. Compendium of Pharmaceuticals and Specialties (CPS). The Canadian Drug Reference for Health Professionals. Ottawa, Canada: Canadian Pharmacists Association, 2006
33. AHFS. AHFS Pharmacologic-Therapeutic Classification (Table of Contents) [Online]. Available from American Hospital Formulary Service: Drug Information for 2006. Bethesda, MD: American Society of Health-System Pharmacists [Last accessed 27 November 2007]
34. Klein B, Klein R, Knudtson M. Intraocular pressure and systemic blood pressure: longitudinal perspective: the Beaver Dam Eye Study. Br J Ophthalmol 2005;89:284-7
35. Müskens R, de Voogd S, Wolfs R, et al. Systemic antihypertensive medication and incident open-angle glaucoma. Ophthalmology 2007;114:2221-6
36. Gordon M, Beiser J, Kass M. Is a history of diabetes mellitus protective against developing primary open-angle glaucoma? Arch Ophthalmol 2008;126:280-1
37. De M, Phan I, Bostrom A et al. Effect of statin and aspirin use on primary open-angle glaucoma progression. Investig Ophthalmol Vis Sci 2006;47;3398-B931. Available at http://abstracts.iovs.org/cgi/content/abstract/ 47/5/3398 [Last accessed 4 August 2008]
38. De Castro D, Punjabi O, Bostrom A et al. Effect of statin drugs and aspirin on progression in glaucoma suspects. Investig Ophthalmol Vis Sci 2006;47;3399-B932. Available at http://abstracts.iovs.org/cgi/content/abstract/ 47/5/3399 [Last accessed 9 April 2008]